Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala

Posts tagged Daljeet S. Kohli

Daljeet Kohli Of IndiaNivesh’s Model Portfolio Of Top Stocks Outperforms



Daljeet Kohli Of IndiaNivesh is well known for his stock picks like Alembic Pharma & J. B. Chem. His Model Portfolio for investors has heavily outperformed the Benchmark Index

Daljeet Kohli’s Stock Pick J. B. Chemicals Is On The Move. Do You Have It In Your Portfolio?



Daljeet Kohli’s stock pick J. B. Chemicals sprinted 7% today. It has given a return of 44% since he recommended it and seems to be headed higher

Daljeet Kohli’s Stock Portfolio Picks For 2014



We like to keep an eye on Daljeet Kohli’s stock picks because there is a chance for profit there. Let’s take a look at his stock picks for 2014 and see whether they have the potential to enrich us

Will Daljeet Kohli’s Latest Stock Pick J.B. Chemicals Also Give Multibagger Returns?



Daljeet Kohli of IndiaNivesh shot into stardom when his stock pick Alembic Pharma became a super-duper multibagger. His latest stock pick J.B. Chemicals is based on the same formula of low risk and high returns. Will it live up to the promise and enrich investors?

Daljeet Kohli’s Stock Pick Alembic Pharma Gives 100% Return



Daljeet Kohli of IndiaNivesh is a soft spoken and unassuming stock market analyst with clear thinking. He likes low profile & well managed stocks which are growing at a steady pace. His latest stock pick Alembic Pharma has thrilled investors with a 100% return in just 9 months

Newer Entries →

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 509 other subscribers

RSS Stocks Talk Forum

  • Piramal Pharma is seeing strong momentum in CDMO. Buy for TP ₹320 (27% upside)
    Piramal Pharma is seeing strong momentum in CDMO. Postponement of the Biosecure Act is unlikely to cause growth related issues as China rebalancing drive by global innovators likely to continue. Other growth levers are intact. Buy for TP ₹320 (27% upside) Download report... Piramal Pharma is seeing strong momentum in CDMO. Buy for TP ₹320 […]
  • The "Golden Crossover" strategy signals a Bullish trend is underway & yields multibagger returns
    Expert says the "Golden Crossover" strategy, where the 50 DMA crosses above the 200 DMA, signals that a Bullish trend is underway. It yields multibagger returns. Top investors & traders use this. There are scanners which reveal when crossover is happening ET's screener shows stocks which have undergone the "golden crossover" in the recent past. […]
  • Hiren Ved has no Banking stocks in his portfolio.
    Hiren Ved has no Bank stocks in his portfolio because Banks are unable to get cheap deposits & lend profitably. People are investing in SIPs instead of FDs & Capital Market stocks are better than Bank stocks. HDFC AMC is a better investment than HDFC Bank [youtube https://www.youtube.com/watch?v=O4SA4czZqY0]
Disclaimer: This is a Fan Site in Rakesh Jhunjhunwala's name. Rakesh Jhunjhunwala is not associated with us and is in no way aware, accountable or responsible for what is stated here. Further, nothing here constiutes investment advice for you to act on. Also, we have a vested interest, and are extremely biased, in everything that we say. So Mind It!